Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shai Shimony

Showing results (1-10 of 75) with videos related to

Pageof 8
Sort By:
Acta Haematologica|November 30, 2023
Untangling Complexities of Acute Myeloid Leukemia Review SeriesShai Shimony, Richard M Stone
American Journal of Hematology|February 4, 2025
Sharpening the Tools to Get the Edge on LeukemiaShai Shimony, Jacqueline S Garcia
British Journal of Haematology|January 8, 2024
Tri-ing to decipher trisomy AMLShai Shimony, Evan C Chen
Clinical Lymphoma, Myeloma & Leukemia|December 15, 2023
SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic LeukemiaShai Shimony, Marlise R Luskin
Blood|November 23, 2023
Unraveling KMT2A-rearranged ALLShai Shimony, Marlise R Luskin
American Journal of Hematology|February 12, 2025
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and ManagementShai Shimony, Maximilian Stahl, Richard M Stone
Current Opinion in Hematology|December 30, 2021
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromesShai Shimony, Richard M Stone, Maximilian Stahl
American Journal of Hematology|January 3, 2023
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and managementShai Shimony, Maximilian Stahl, Richard M Stone
Blood Advances|June 30, 2023
Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemiaShai Shimony, Daniel J DeAngelo, Marlise R Luskin
Leukemia & Lymphoma|January 26, 2026
Pericardial effusion and tamponade as a rare cardiac toxicity of covalent BTK inhibitors in CLL-a multi-modality studyLiron Hofstetter, Shai Shimony, Adi Sherban, et al.
Pageof 8

Showing results (1-10 of 75) with videos related to

Sort By:
Pageof 8
Acta Haematologica|November 30, 2023
Untangling Complexities of Acute Myeloid Leukemia Review SeriesShai Shimony, Richard M Stone
American Journal of Hematology|February 4, 2025
Sharpening the Tools to Get the Edge on LeukemiaShai Shimony, Jacqueline S Garcia
British Journal of Haematology|January 8, 2024
Tri-ing to decipher trisomy AMLShai Shimony, Evan C Chen
Clinical Lymphoma, Myeloma & Leukemia|December 15, 2023
SOHO State of the Art Updates and Next Questions | Approach to Older Adults With Phildadelphia-Chromosome Negative Acute Lymphoblastic LeukemiaShai Shimony, Marlise R Luskin
Blood|November 23, 2023
Unraveling KMT2A-rearranged ALLShai Shimony, Marlise R Luskin
American Journal of Hematology|February 12, 2025
Acute Myeloid Leukemia: 2025 Update on Diagnosis, Risk-Stratification, and ManagementShai Shimony, Maximilian Stahl, Richard M Stone
Current Opinion in Hematology|December 30, 2021
Venetoclax combination therapy in acute myeloid leukemia and myelodysplastic syndromesShai Shimony, Richard M Stone, Maximilian Stahl
American Journal of Hematology|January 3, 2023
Acute myeloid leukemia: 2023 update on diagnosis, risk-stratification, and managementShai Shimony, Maximilian Stahl, Richard M Stone
Blood Advances|June 30, 2023
Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemiaShai Shimony, Daniel J DeAngelo, Marlise R Luskin
Leukemia & Lymphoma|January 26, 2026
Pericardial effusion and tamponade as a rare cardiac toxicity of covalent BTK inhibitors in CLL-a multi-modality studyLiron Hofstetter, Shai Shimony, Adi Sherban, et al.
Pageof 8